FDA Grants Priority Review to Immunotherapy Combination with … – Drug Discovery & Development
Drug Discovery & Development |
FDA Grants Priority Review to Immunotherapy Combination with …
Drug Discovery & Development Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for KEYTRUDA, the company’s anti-PD-1 therapy, based … FDA Grants Priority Review for Immunotherapy-Based Lung Cancer …Curetoday.com |
FierceBiotech |
Feng Zhang quietly starting new CRISPR-based company: report
FierceBiotech According to the Boston Business Journal’s report, Beam is pursing methods to more precisely edit individual base pairs without snipping the molecule’s double-helix structure. An additional Zhang effort, Arbor Biotechnologies, recently announced $15.6 … New startup promises ‘world’s first’ CRISPR-powered disease dete …WAOW New startup promises ‘world’s first’ CRISPR-powered disease detectionnews9.com KWTV |
9&10 News |
Healthy Living: Stem Cell Therapy – 9 & 10 News
9&10 News It’s estimated that nearly 1.3 million Americans are legally blind. Now a doctor in Florida is helping people who have no other treatment options regain some vision using a unique procedure, using stem cells and patients are saying seeing is believing … |
9&10 News |
Healthy Living: Stem Cell Therapy – 9 & 10 News
9&10 News It’s estimated that nearly 1.3 million Americans are legally blind. Now a doctor in Florida is helping people who have no other treatment options regain some vision using a unique procedure, using stem cells and patients are saying seeing is believing … |